St. Baldrick’s Foundation Supports Innovative Research in Pediatric Cancer at CHLA
August 5, 2016
Yves De Clerck, MD
Content related to Team Led by Children’s Hospital Los Angeles Researcher Generates Comprehensive, Developmental Map of Human T-cells
Could CAR-T Version 2.0 Be on the Horizon?
March 31, 2020
CHLA scientists work toward a new therapy to target resistant leukemia. Their study, recently published in the journal Leukemia, shows that these new CAR-T cells could be the answer to resistant
Cell Therapy Program Expands
February 15, 2021
With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.
Creating a Safe CAR T-Cell Therapy to Fight Solid Tumors in Children
January 22, 2021
Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.
When Good Macrophages go Bad
December 5, 2018
New study reveals how cancer manipulates our immune system to become harder to treat Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective
Five Things Parents Need to Know About CAR T-Cell Therapy for Cancer
September 16, 2020
In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to
Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid Tumors
March 1, 2023
A single blood test can detect various tumor types less invasively than tissue biopsy.
What Makes a Cell Turn Cancerous?
March 14, 2019
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result